The role of cadherin/catenin complex in malignant melanoma.

In the present review article the role of cadherin/catenin complex in cases of malignant melanoma is discussed in some detail. Cadherins represent the most important superfamily of adhesion molecules with epithelial E-cadherin being the most studied. Its role in normal state as well as in cancer invasion and metastasis and some other pathologies is crucial. E-cadherin expression is altered in malignant melanomas and its downregulation or absence is associated with melanoma invasion and metastasis potential. A shift from E-cadherin expression to neural N-cadherin expression in melanocytes is also detected in malignant melanomas formation. In addition, a discussion regarding the role of placental P-cadherin and vascular endothelial VE-cadherin as well as the recently identified molecule of dysadherin, is attempted in brief.

[1]  G. V. van Muijen,et al.  Markers of melanocytic tumour progression , 1998, The Journal of pathology.

[2]  E. Voura,et al.  Cell–cell interactions during transendothelial migration of tumor cells , 1998, Microscopy research and technique.

[3]  M. Hendrix,et al.  Molecular plasticity of human melanoma cells , 2003, Oncogene.

[4]  M. Bar‐eli,et al.  Molecular changes in human melanoma metastasis. , 1998, Histology and histopathology.

[5]  P. Hersey,et al.  Expression of catenins and p120cas in melanocytic nevi and cutaneous melanoma: deficient alpha-catenin expression is associated with melanoma progression. , 1999, Pathology.

[6]  J. Nesland,et al.  Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma , 2004, Modern Pathology.

[7]  B. Gumbiner,et al.  Cell Adhesion: The Molecular Basis of Tissue Architecture and Morphogenesis , 1996, Cell.

[8]  M. N. Epstein,et al.  A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. , 1984, Human pathology.

[9]  K. A. Meleo Tumors of the skin and associated structures. , 1997, The Veterinary clinics of North America. Small animal practice.

[10]  Yuhei Yamamoto,et al.  Epigenetic silencing of E- and P-cadherin gene expression in human melanoma cell lines. , 2004, International journal of oncology.

[11]  M. Nieto,et al.  The snail superfamily of zinc-finger transcription factors , 2002, Nature Reviews Molecular Cell Biology.

[12]  Christophe Stove,et al.  P-cadherin promotes cell-cell adhesion and counteracts invasion in human melanoma. , 2005, Cancer research.

[13]  S. Hirohashi,et al.  Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Bar‐eli,et al.  Transcriptional regulation of metastasis-related genes in human melanoma , 2004, Clinical & Experimental Metastasis.

[15]  S. Imamura,et al.  Identification of novel cadherins expressed in human melanoma cells. , 1997, The Journal of investigative dermatology.

[16]  M. Herlyn,et al.  Normal human melanocyte homeostasis as a paradigm for understanding melanoma. , 2005, The journal of investigative dermatology. Symposium proceedings.

[17]  R. Poulsom,et al.  E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. , 1993, The American journal of pathology.

[18]  D. Elder,et al.  E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. , 2000, The American journal of pathology.

[19]  M. Hendrix,et al.  Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2). , 2001, Cancer research.

[20]  A. Bosserhoff,et al.  Loss of E-cadherin Expression in Melanoma Cells Involves Up-regulation of the Transcriptional Repressor Snail* , 2001, The Journal of Biological Chemistry.

[21]  S. Hirohashi,et al.  E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. , 1994, Journal of cell science.

[22]  B. Parr,et al.  The body language of cells: The intimate connection between cell adhesion and behavior , 1995, Cell.

[23]  T. Horikawa,et al.  Expression of E and P-cadherin by melanoma cells decreases in progressive melanomas and following ultraviolet radiation. , 1996, The Journal of investigative dermatology.

[24]  L. Akslen,et al.  Importance of P-Cadherin, β-Catenin, and Wnt5a/Frizzled for Progression of Melanocytic Tumors and Prognosis in Cutaneous Melanoma , 2005, Clinical Cancer Research.

[25]  J. Kononen,et al.  Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. , 1996, American journal of clinical pathology.

[26]  K Satyamoorthy,et al.  N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. , 2001, Cancer research.

[27]  M. Herlyn,et al.  Dynamics of intercellular communication during melanoma development. , 2000, Molecular medicine today.

[28]  G. Christofori,et al.  The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. , 1999, Trends in biochemical sciences.

[29]  A. Amoresano,et al.  The structure of the oligosaccharides of N-cadherin from human melanoma cell lines , 2003, Glycoconjugate Journal.

[30]  A. Bosserhoff,et al.  Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma , 2006, Oncogene.

[31]  P. McCrea,et al.  Catenins as mediators of the cytoplasmic functions of cadherins , 1993, Journal of Cell Science.

[32]  Gerhard Christofori,et al.  Changing neighbours, changing behaviour: cell adhesion molecule‐mediated signalling during tumour progression , 2003, The EMBO journal.

[33]  K. Nakagawa,et al.  Soluble E-cadherin fragments increased in circulation of cancer patients. , 1994, British Journal of Cancer.

[34]  M. Takeichi,et al.  Cadherin cell adhesion receptors as a morphogenetic regulator. , 1991, Science.

[35]  D. Lev,et al.  Cellular Adhesion Pathways and Metastatic Potential of Human Melanoma , 2002, Cancer biology & therapy.

[36]  M. Takeichi,et al.  Neural crest emigration from the neural tube depends on regulated cadherin expression. , 1998, Development.

[37]  Daniel S. Miller,et al.  The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer , 2000, Cancer.

[38]  W. Birchmeier,et al.  Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. , 1993, The American journal of pathology.

[39]  M. Pasdar,et al.  Plasticity of cadherin-catenin expression in the melanocyte lineage. , 2000, Pigment cell research.

[40]  E. Dejana,et al.  Perspectives Series: Cell Adhesion in Vascular Biology Endothelial Adherens Junctions: Implications in the Control of Vascular Permeability and Angiogenesis , 1996 .

[41]  S. Hirohashi,et al.  Expression patterns of dysadherin and E-cadherin in lymph node metastases of colorectal carcinoma , 2006, Virchows Archiv.

[42]  S. Hirohashi,et al.  Dysadherin Expression in Head and Neck Squamous Cell Carcinoma: Association With Lymphangiogenesis and Prognostic Significance , 2006, The American journal of surgical pathology.

[43]  M. Herlyn,et al.  Dynamics of cell interactions and communications during melanoma development. , 2002, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[44]  M. Tronnier,et al.  Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression , 2004, Journal of cutaneous pathology.

[45]  M. Herlyn,et al.  Shifts in cadherin profiles between human normal melanocytes and melanomas. , 1996, The journal of investigative dermatology. Symposium proceedings.

[46]  E. Danen,et al.  E‐cadherin expression in human melanoma , 1996, Melanoma research.

[47]  M. Herlyn,et al.  Adhesion, migration and communication in melanocytes and melanoma. , 2005, Pigment cell research.

[48]  R. Kemler,et al.  Molecular organization of the uvomorulin-catenin complex , 1992, The Journal of cell biology.

[49]  M. Takeichi,et al.  Expression of cadherin cell adhesion molecules during human skin development: morphogenesis of epidermis, hair follicles and eccrine sweat ducts , 1992, Archives of Dermatological Research.

[50]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[51]  G. Cowley,et al.  CADHERIN EXPRESSION IN MELANOCYTIC NAEVI AND MALIGNANT MELANOMAS , 1996, The Journal of pathology.

[52]  Y. Horiguchi,et al.  Ultrastructural localization of E-cadherin cell adhesion molecule on the cytoplasmic membrane of keratinocytes in vivo and in vitro. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[53]  A. Bosserhoff,et al.  A secreted form of P-cadherin is expressed in malignant melanoma. , 2005, Experimental cell research.

[54]  K. Syrigos,et al.  E‐cadherin/catenin complex in benign and malignant melanocytic lesions , 1998, The Journal of pathology.

[55]  M. Mareel,et al.  The E-cadherin/catenin complex in invasion and metastasis. , 1996, Current topics in microbiology and immunology.

[56]  Paul S. Meltzer,et al.  Expression and functional significance of VE-cadherin in aggressive human melanoma cells: Role in vasculogenic mimicry , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[57]  L. Liotta,et al.  Biology of melanoma invasion and metastasis. , 1987, Pigment cell research.

[58]  Judith P. Johnson Cell Adhesion Molecules in the Development and Progression of Malignant Melanoma , 2004, Cancer and Metastasis Reviews.

[59]  W. Birchmeier,et al.  Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion , 1989, The Journal of cell biology.

[60]  P. Dixon,et al.  Equine nasal and paranasal sinus tumours: part 2: a contribution of 28 case reports. , 1999, Veterinary journal.

[61]  N. Chen,et al.  Transendothelial migration of melanoma cells involves N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway. , 2005, Molecular biology of the cell.

[62]  W. Birchmeier,et al.  E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells , 1991, The Journal of cell biology.

[63]  S. Hirohashi,et al.  Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma , 2005, Cancer.

[64]  J. Jankowski,et al.  Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours. , 1999, Molecular pathology : MP.

[65]  F. Furukawa,et al.  E- and P-cadherin expression in tumor tissues and soluble E-cadherin levels in sera of patients with skin cancer. , 1996, Journal of dermatological science.

[66]  M. Goldschmidt,et al.  A Comparative Review of Melanocytic Neoplasms , 2002, Veterinary pathology.

[67]  D. Elder,et al.  Human melanoma progression in skin reconstructs : biological significance of bFGF. , 2000, The American journal of pathology.

[68]  M. Herlyn,et al.  Role of cadherins and matrixins in melanoma , 2001, Current opinion in oncology.

[69]  K. Toda,et al.  Roles of E‐ and P‐cadherin in the human skin , 1997, Microscopy research and technique.

[70]  M. Herlyn,et al.  Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression. , 2000, Journal of cell science.

[71]  S. Hirohashi,et al.  Involvement of dysadherin and E-cadherin in the development of testicular tumours , 2005, British Journal of Cancer.

[72]  B. Gumbiner,et al.  Molecular and functional analysis of cadherin-based adherens junctions. , 1997, Annual review of cell and developmental biology.

[73]  Mina J. Bissell,et al.  Putting tumours in context , 2001, Nature Reviews Cancer.

[74]  W. Birchmeier,et al.  Molecular mechanisms leading to cell junction (cadherin) deficiency in invasive carcinomas. , 1993, Seminars in cancer biology.

[75]  M. Bar‐eli Molecular mechanisms of melanoma metastasis , 1997, Journal of cellular physiology.